Literature DB >> 11336474

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.

A Hildesheim1, R Herrero, P E Castle, S Wacholder, M C Bratti, M E Sherman, A T Lorincz, R D Burk, J Morales, A C Rodriguez, K Helgesen, M Alfaro, M Hutchinson, I Balmaceda, M Greenberg, M Schiffman.   

Abstract

We examined factors associated with high-grade squamous intraepithelial lesions (HSIL) and cervical cancer among human papillomavirus (HPV)-infected women in a prevalent case-control study conducted within a population-based cohort of 10 077 women in Costa Rica. We compared 146 women with HPV-positive HSIL or cancer (HSIL/CA) against 843 HPV-positive women without evidence of HSIL/CA. Subjects completed a risk factor questionnaire. We evaluated the associations between exposures and HSIL/CA among women positive for any HPV and restricted to those positive for high-risk HPV types. Risk of HSIL/CA increased with increasing number of live births (P(trend)= 0.04). Women who smoked 6+ cigarettes/day had a RR for HSIL/CA of 2.7 (95% CI = 1.1-6.7) compared to non-smokers. Current use of barrier contraceptives was associated with a reduction in risk of HSIL/CA (RR = 0.39; 95% CI = 0.16-0.96). Sexual behaviour and a self-reported history of sexually transmitted diseases (STDs) other than HPV were not associated with HSIL/CA. Oral contraceptive use was associated with HSIL/CA among women with <3 pregnancies. Effects were similar in analysis restricted to women positive for high-risk HPV types. Among women positive for high-risk HPV types, 44% of HSIL/CA could be attributed to multiparity (>/=3 pregnancies) and/or smoking. Among HPV-positive women, multiparity and smoking are risk factors for HSIL/CA. Oral contraceptive use may be associated with HSIL/CA in subgroups of women. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Year:  2001        PMID: 11336474      PMCID: PMC2363883          DOI: 10.1054/bjoc.2001.1779

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.

Authors:  M Schiffman; R Herrero; A Hildesheim; M E Sherman; M Bratti; S Wacholder; M Alfaro; M Hutchinson; J Morales; M D Greenberg; A T Lorincz
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

2.  The association between pregnancy and human papilloma virus prevalence.

Authors:  E M Smith; S R Johnson; D Jiang; S Zaleski; C F Lynch; S Brundage; R D Anderson; L P Turek
Journal:  Cancer Detect Prev       Date:  1991

3.  Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer.

Authors:  V Moreno; N Muñoz; F X Bosch; S de Sanjosé; L C Gonzalez; L Tafur; M Gili; I Izarzugaza; C Navarro; A Vergara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Jul-Aug       Impact factor: 4.254

4.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

5.  Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

Authors:  N Muñoz; F X Bosch; S de Sanjosé; A Vergara; A del Moral; M T Muñoz; L Tafur; M Gili; I Izarzugaza; P Viladiu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Sep-Oct       Impact factor: 4.254

6.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

7.  Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones.

Authors:  R Mittal; K Tsutsumi; A Pater; M M Pater
Journal:  Obstet Gynecol       Date:  1993-01       Impact factor: 7.661

8.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

9.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

10.  Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.

Authors:  T M Becker; C M Wheeler; N S McGough; C A Stidley; C A Parmenter; M H Dorin; S W Jordan
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

View more
  42 in total

Review 1.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.

Authors:  Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07       Impact factor: 4.254

3.  Lifestyle behaviors in Massachusetts adult cancer survivors.

Authors:  Amy Linsky; Joshua Nyambose; Tracy A Battaglia
Journal:  J Cancer Surviv       Date:  2010-12-05       Impact factor: 4.442

4.  Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.

Authors:  Kirsten Egebjerg Jensen; Sven Schmiedel; Kirsten Frederiksen; Bodil Norrild; Thomas Iftner; Susanne K Kjær
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-26       Impact factor: 4.254

5.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254

6.  Coverage of Jade Goody's cervical cancer in UK newspapers: a missed opportunity for health promotion?

Authors:  Shona Hilton; Kate Hunt
Journal:  BMC Public Health       Date:  2010-06-24       Impact factor: 3.295

7.  Association between smoking and size of anal warts in HIV-infected women.

Authors:  H N Luu; E S Amirian; R P Beasley; L Piller; W Chan; M E Scheurer
Journal:  Int J STD AIDS       Date:  2012-11       Impact factor: 1.359

8.  Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.

Authors:  Tiffany G Harris; Leslie Miller; Shalini L Kulasingam; Qinghua Feng; Nancy B Kiviat; Stephen M Schwartz; Laura A Koutsky
Journal:  Am J Obstet Gynecol       Date:  2009-05       Impact factor: 8.661

9.  Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women.

Authors:  Marina Munoz; Milena Camargo; Sara C Soto-De Leon; Ricardo Sanchez; Andrea C Pineda-Peña; Antonio Perez-Prados; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

Review 10.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.